Ziel
Migraine is a common brain disorder, typically characterised by recurring, incapacitating attacks of 1-3 days of severe headache, autonomic dysfunction, and sometimes aura symptoms. The disease affects 15% of all European citizens including children, ranks among the WHO top 12 of most disabling and undertreated disorders, and is responsible for the highest socio-economic burden of any brain ailment in Europe.
Migraine attacks typically strike bi-monthly, and in 25% of patients once a week or more. Many patients may progress to “chronic migraine” with near-daily headaches and high disability (chronification). There is desperate need of effective prophylactic treatments to prevent attacks and chronification. Current medications are only moderately effective and often poorly tolerated, mainly due to lack of understanding of how attacks are triggered and why their frequency may increase so dramatically. Overuse of painkillers and triptans, are recognised risk factors for chronification, as are comorbid depression, stress, and obesity. Central sensitisation of pain signalling pathways appears to be pivotal to the chronification proces.
EUROHEADPAIN will use established and evolving human and translational animal models to: (a) identify pathways and biomarkers for the triggering and chronification of migraine attacks; (b) decipher the modulatory effects of (hypothalamic) brain circuitries on trigeminal processing, sensitisation, and chronification; (c) assess the effects and mode of action of migraine-provoking molecules; and (d) evaluate the efficacy and mode of action of neuromodulation (in collaboration with an SME) and second messenger-blocking drugs in the treatment of chronic migraine. We expect important spin-offs to the understanding of other chronic pain disorders. The pharmaceutical industry will be engaged once treatable targets have been identified to develop novel treatments to reduce the disability and socio-economic burden due to migraine.
Wissenschaftliches Gebiet
Programm/Programme
Aufforderung zur Vorschlagseinreichung
FP7-HEALTH-2013-INNOVATION-1
Andere Projekte für diesen Aufruf anzeigen
Finanzierungsplan
CP-FP - Small or medium-scale focused research projectKoordinator
2333 ZA Leiden
Niederlande
Auf der Karte ansehen
Beteiligte (13)
4000 Liege
Auf der Karte ansehen
20251 Hamburg
Auf der Karte ansehen
Beteiligung beendet
CB10 1SA SAFFRON WALDEN
Auf der Karte ansehen
00014 Helsingin Yliopisto
Auf der Karte ansehen
Beteiligung beendet
QLD 4006 Herston
Auf der Karte ansehen
34136 Trieste
Auf der Karte ansehen
91054 Erlangen
Auf der Karte ansehen
Beteiligung beendet
94607 OAKLAND CA
Auf der Karte ansehen
3400 Hillerod
Auf der Karte ansehen
4040 HERSTAL
Auf der Karte ansehen
6720 Szeged
Auf der Karte ansehen
WC2R 2LS London
Auf der Karte ansehen
4001 Brisbane
Auf der Karte ansehen